Skip to main content
. Author manuscript; available in PMC: 2012 Apr 24.
Published in final edited form as: Curr Breast Cancer Rep. 2009 Sep;1(3):148–156. doi: 10.1007/s12609-009-0021-5

Figure 1.

Figure 1

Design of early-stage biomarker-based chemoprevention trials in women at high risk for breast cancer. FNA—fine-needle aspiration; IGF—insulin-like growth factor; IGFBP—insulin-like growth factor binding proteins. (From Fabian et al. [52]; with permission.)